Clinical & Experimental Immunology

The chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and configure intricate patterns of disease susceptibility
pp. 1-12(12)
Authors: Colobran, R.; Pujol-Borrell, R.; Armengol, M. P.; Juan, M.

Bacterial superantigens and T cell receptor β-chain-bearing T cells in the immunopathogenesis of ulcerative colitis
pp. 13-21(9)
Authors: Shiobara, N.; Suzuki, Y.; Aoki, H.; Gotoh, A.; Fujii, Y.; Hamada, Y.; Suzuki, S.; Fukui, N.; Kurane, I.; Itoh, T.; Suzuki, R.

Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects
pp. 22-29(8)
Authors: Hodge, G.; Nairn, J.; Holmes, M.; Reynolds, P. N.; Hodge, S.

The clearance kinetics of autologous RhD-positive erythrocytes coated ex vivo with novel recombinant and monoclonal anti-D antibodies
pp. 30-41(12)
Authors: Chapman, G. E.; Ballinger, J. R.; Norton, M. J.; Parry-Jones, D. R.; Beharry, N. A.; Cousins, C.; Dash, C. H.; Peters, A. M.

Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA)
pp. 42-48(7)
Authors: Talor, M. V.; Stone, J. H.; Stebbing, J.; Barin, J.; Rose, N. R.; Burek, C. L.

Overexpression of the autoantigen IA-2 puts beta cells into a pre-apoptotic state: autoantigen-induced, but non-autoimmune-mediated, tissue destruction
pp. 49-60(12)
Authors: Harashima, S.-I.; Harashima, C.; Nishimura, T.; Hu, Y.; Notkins, A. L.

A case study on the effect of neutralizing antibodies to interferon beta 1b in multiple sclerosis patients followed for 3 years with monthly imaging
pp. 61-67(7)
Authors: Chiu, A. W.; Ehrmantraut, M.; Richert, N. D.; Ikonomidou, V. N.; Pellegrini, S.; McFarland, H. F.; Frank, J. A.; Bagnato, F.

Determination of glutamic acid decarboxylase antibodies (GADA) IgG subclasses − comparison of three immunoprecipitation assays (IPAs)
pp. 68-74(7)
Authors: Hillman, M.; Törn, C.; Landin-Olsson, M.

Dynamic changes in CD4⁺ CD25^{+ high} T cell apoptosis after the diagnosis of type 1 diabetes
pp. 75-82(8)
Authors: Glisic-Milosavljevic, S.; Wang, T.; Koppen, M.; Kramer, J.; Ehlenbach, S.; Waukau, J.; Jailwala, P.; Jana, S.; Alemzadeh, R.; Ghosh, S.

Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease
pp. 83-90(8)
Authors: Breunis, W. B.; Biezeveld, M. H.; Geissler, J.; Kuipers, I. M.; Lam, J.; Ottenkamp, J.; Hutchinson, A.; Welch, R.; Chanock, S. J.; Kuijpers, T. W.

Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study
pp. 91-98(8)
Authors: Vincenti, D.; Carrara, S.; Butera, O.; Bizzoni, F.; Casetti, R.; Girardi, E.; Goletti, D.

Extremes ofl-ficolin concentration in children with recurrent infections are associated with single nucleotide polymorphisms in the FCN2 gene
pp. 99-104(6)
Authors: Cedzynski, M.; Nuytinck, L.; Atkinson, A. P. M.; St Swierzko, A.; Zeman, K.; Szemraj, J.; Szala, A.; Turner, M. L.; Kilpatrick, D. C.

Reduced apoptosis and increased inflammatory cytokines in granulomas caused by tuberculous compared to non-tuberculous mycobacteria: role of MPT64 antigen in apoptosis and immune response
pp. 105-113(9)
Authors: Mustafa, T.; Wiker, H. G.; Mørkve, O.; Sviland, L.

Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships
pp. 114-123(10)
Authors: El Houda Agueznay, N.; Badoual, C.; Hans, S.; Gey, A.; Vingert, B.; Peyrard, S.; Quintin-Colonna, F.; Ravel, P.; Bruneval, P.; Roncelin, S.; Lelongt, B.; Bertoglio, J.; Fridman, W. H.; Brasnu, D.; Tartour, E.

85-kDa cytosolic phospholipase A₂ group IVα gene promoter polymorphisms in patients with severe asthma: a gene expression and case-control study
pp. 124-131(8)
Authors: Sokolowska, M.; Borowiec, M.; Ptasinska, A.; Cieslak, M.; Shelhamer, J. H.; Kowalski, M. L.; Pawliczak, R.

Antigen-induced B cell apoptosis is independent of complement C4
pp. 132-139(8)
Authors: Faust, K. B.; Finke, D.; Klempt-Giessing, K.; Randers, K.; Zachrau, B.; Schlenke, P.; Kirchner, H.; Goerg, S.

Antibodies directed against ribosomal P proteins cross-react with phospholipids
pp. 140-143(4)
Authors: Caponi, L.; Anzilotti, C.; Longombardo, G.; Migliorini, P.

Itraconazole-mediated inhibition of calcium entry into platelet-activating factor-stimulated human neutrophils is due to interference with production of leukotriene B₄
pp. 144-150(7)
Authors: Steel, H. C.; Tintinger, G. R.; Theron, A. J.; Anderson, R.

Suppression of lipopolysaccharide- and tumour necrosis factor-α-induced interleukin (IL)-8 expression by glucocorticoids involves changes in IL-8 promoter acetylation
pp. 151-157(7)
Authors: Tsaprouni, L. G.; Ito, K.; Adcock, I. M.; Punchard, N.

The intriguing normal acute inflammatory response in mice lacking vimentin
pp. 158-168(11)
Authors: Moisan, É; Chiasson, S.; Girard, D.

A murine model of appendicitis and the impact of inflammation on appendiceal lymphocyte constituents
pp. 169-178(10)
Authors: Watson Ng, W. S.; Hampartzoumian, T.; Lloyd, A. R.; Grimm, M. C.

Gold causes genetically determined autoimmune and immunostimulatory responses in mice
pp. 179-188(10)
Authors: Havarinasab, S.; Johansson, U.; Pollard, K. M.; Hultman, P.

Mercury exposure as a model for deviation of cytokine responses in experimental Lyme arthritis: HgCl₂ treatment decreases T helper cell type 1-like responses and arthritis severity but delays eradication of Borrelia burgdorferi in C3H/HeN mice
pp. 189-197(9)
Authors: Ekerfelt, C.; Andersson, M.; Olausson, A.; Bergström, S.; Hultman, P.